Results 61 to 70 of about 700,178 (349)

Recanalization treatment for acute ischemic stroke: 3-month outcome before and after implementation of routine endovascular treatment

open access: yeseNeurologicalSci, 2022
Background and purpose: Endovascular treatment for acute ischemic stroke has become a recommended treatment option for selected patients after several randomized controlled trials have shown the effectiveness of endovascular treatment.
Kati Valkonen   +7 more
doaj   +1 more source

The risk factors of early hemorrhage after emergency intravenous thrombolysis in patients with acute ischemic stroke.

open access: yesAnnals of Palliative Medicine, 2021
BACKGROUND At present, the treatment of acute ischaemic stroke (AIS) by aticepase (rt-PA) in emergency veins has become the main treatment mode in hospital, but the research on early hemorrhage complications in patients with emergency thrombolysis is ...
Xuemei Zhang   +10 more
semanticscholar   +1 more source

Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction

open access: yesApplied Bionics and Biomechanics, 2022
Objective. To assess the clinical effect of butylphthalide combined with rt-PA intravenous thrombolysis in the treatment of acute cerebral infarction (ACI). Methods. Totally, 312 acute cerebral infarction patients were included in this research. Those in
Xiangchen Zhou   +3 more
doaj   +1 more source

Extent of hypoattenuation on CT angiography source images in Basilar Artery occlusion: prognostic value in the Basilar Artery International Cooperation Study [PDF]

open access: yes, 2011
<p><b>Background and Purpose:</b> The posterior circulation Acute Stroke Prognosis Early CT Score (pc-ASPECTS) quantifies the extent of early ischemic changes in the posterior circulation with a 10-point grading system.
Algra, Ale   +18 more
core   +1 more source

Recanalization of extracranial internal carotid artery occlusion after i.v. thrombolysis for acute ischemic stroke. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Although extracranial internal carotid artery (e-ICA) occlusion is a common pathology in patients undergoing intravenous thrombolysis for treatment of acute ischemic stroke, no data on e-ICA recanalization rate or potential effects on outcome
Raimund Pechlaner   +6 more
doaj   +1 more source

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis.

open access: yesJournal of the American Medical Association (JAMA)
Importance The benefit of intravenous thrombolysis (IVT) for acute ischemic stroke declines with longer time from symptom onset, but it is not known whether a similar time dependency exists for IVT followed by thrombectomy.
J. Kaesmacher   +33 more
semanticscholar   +1 more source

Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions

open access: yesStroke, 2020
Supplemental Digital Content is available in the text. Background and Purpose: Accumulating evidence from randomized controlled clinical trials suggests that tenecteplase may represent an effective treatment alternative to alteplase for acute ischemic ...
A. Katsanos   +11 more
semanticscholar   +1 more source

Intravenous Thrombolysis in Posterior Circulation Stroke [PDF]

open access: yesFrontiers in Neurology, 2019
Background: Intravenous thrombolysis (IVT) is a standard treatment for both anterior circulation ischemic stroke (ACIS) and posterior circulation ischemic stroke (PCIS). PCIS is a clinical syndrome associated with ischemia-related changes in the territory of the posterior circulation arteries.
Tomáš Dorňák   +3 more
openaire   +3 more sources

Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke

open access: yesFrontiers in Neurology, 2019
We report a case of intravenous thrombolysis in acute ischemic stroke of anterior choroidal artery following the antagonization of dabigatran with idarucizumab.
Maren Hieber, Juergen Bardutzky
doaj   +1 more source

Home - About - Disclaimer - Privacy